MedPath

Clinical feasibility of ASL-MRI to assess perfusional delay in cerebrovascular disease

Not Applicable
Recruiting
Conditions
cerebrovascular disease (moyamoya disease, atherosclerotic cerebrovascular disease, stroke, arteriovenous malformation etc.)
Registration Number
JPRN-UMIN000028771
Lead Sponsor
Department of Neurosurgery, Tokyo Medical and Dental University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
550
Inclusion Criteria

Not provided

Exclusion Criteria

*denial from the patient *neurological disease other than cerebrovascular disease (brain tumor, epilepsy, etc) *unable to perform MRI

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. correlation with other modalities (PET, SPECT, DSC) 2. difference among disease (moyamoya disease and atherosclerotic cerebrovascular disease etc.) and normal subjects 3. chronological change including postoperative change 4. difference among age 5. correlation between arterial transit time calculated from ASL-MRI using 5 postlabeling delays and ASL ratio in normal subjects
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath